David W Gryska - Net Worth and Insider Trading
David W Gryska Net Worth
The estimated net worth of David W Gryska is at least $10 Million dollars as of 2024-04-24. David W Gryska is the Director of Seagen Inc and owns about 40,253 shares of Seagen Inc (SGEN) stock worth over $9 Million. David W Gryska is the Executive Vice President, CFO of Incyte Corp and owns about 10,970 shares of Incyte Corp (INCY) stock worth over $566,601. David W Gryska is also the CFO of Celgene Corp and owns about 3,228 shares of Celgene Corp (CELG) stock worth over $349,399. Besides these, David W Gryska also holds PDL BioPharma Inc (PDLI) . Details can be seen in David W Gryska's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David W Gryska has not made any transactions after 2022-11-11 and currently still holds the listed stock(s).
Transaction Summary of David W Gryska
David W Gryska Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David W Gryska owns 9 companies in total, including GW Pharmaceuticals PLC (GWPH) , PDL BioPharma Inc (PDLI) , and Aerie Pharmaceuticals Inc (AERI) among others .
Click here to see the complete history of David W Gryska’s form 4 insider trades.
Insider Ownership Summary of David W Gryska
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GWPH | GW Pharmaceuticals PLC | 2020-09-14 | director |
PDLI | PDL BioPharma Inc | 2020-12-30 | director |
AERI | Aerie Pharmaceuticals Inc | 2013-10-25 | director |
SGEN | Seagen Inc | 2022-11-11 | director |
INCY | Incyte Corp | 2018-02-21 | Executive Vice President & CFO |
ARGSQ | Argos Therapeutics Inc | 2014-02-06 | director |
MYRX | Myrexis Inc | 2012-05-11 | director & Chief Operating Officer |
FBRX | Forte Biosciences Inc | 2023-01-10 | director |
MNMD | Mind Medicine Inc | 2023-06-21 | director |
David W Gryska Latest Holdings Summary
David W Gryska currently owns a total of 4 stocks. Among these stocks, David W Gryska owns 40,253 shares of Seagen Inc (SGEN) as of November 11, 2022, with a value of $9 Million and a weighting of 90.92%. David W Gryska owns 10,970 shares of Incyte Corp (INCY) as of February 21, 2018, with a value of $566,601 and a weighting of 5.6%. David W Gryska also owns 3,228 shares of Celgene Corp (CELG) as of May 4, 2010, with a value of $349,399 and a weighting of 3.45%. The other 1 stocks PDL BioPharma Inc (PDLI) have a combined weighting of 0.03% among all his current holdings.
Latest Holdings of David W Gryska
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGEN | Seagen Inc | 2022-11-11 | 40,253 | 228.74 | 9,207,471 |
INCY | Incyte Corp | 2018-02-21 | 10,970 | 51.65 | 566,601 |
CELG | Celgene Corp | 2010-05-04 | 3,228 | 108.24 | 349,399 |
PDLI | PDL BioPharma Inc | 2020-12-30 | 1,387 | 2.47 | 3,426 |
Holding Weightings of David W Gryska
David W Gryska Form 4 Trading Tracker
According to the SEC Form 4 filings, David W Gryska has made a total of 8 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Seagen Inc is the sale of 7,500 shares on November 11, 2022, which brought David W Gryska around $968,250.
According to the SEC Form 4 filings, David W Gryska has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 1,952 shares on February 21, 2018, which brought David W Gryska around $167,013.
According to the SEC Form 4 filings, David W Gryska has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 76,186 shares on May 4, 2010, which brought David W Gryska around $2 Million.
More details on David W Gryska's insider transactions can be found in the Insider Trading History of David W Gryska table.Insider Trading History of David W Gryska
- 1
David W Gryska Trading Performance
David W Gryska Ownership Network
Ownership Network List of David W Gryska
Ownership Network Relation of David W Gryska
David W Gryska Owned Company Details
What does GW Pharmaceuticals PLC do?
Who are the key executives at GW Pharmaceuticals PLC?
David W Gryska is the director of GW Pharmaceuticals PLC. Other key executives at GW Pharmaceuticals PLC include Chief Legal Officer Douglas B. Snyder , Chief Medical Officer Volker Knappertz , and Secretary Adam D. George .
GW Pharmaceuticals PLC (GWPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of GW Pharmaceuticals PLC (GWPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GW Pharmaceuticals PLC (GWPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
GW Pharmaceuticals PLC (GWPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
GW Pharmaceuticals PLC Insider Transactions
David W Gryska Mailing Address
Above is the net worth, insider trading, and ownership report for David W Gryska. You might contact David W Gryska via mailing address: 749 N Mary Ave, Sunnyvale Ca 94085.